Page last updated: 2024-10-25

desipramine and Remission, Spontaneous

desipramine has been researched along with Remission, Spontaneous in 2 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Faraone, SV1
Biederman, J1
Spencer, T1
Wilens, T1
Seidman, LJ1
Mick, E1
Doyle, AE1
Berner, P1
Kryspin-Exner, K1
Poeldinger, W1

Reviews

1 review available for desipramine and Remission, Spontaneous

ArticleYear
Attention-deficit/hyperactivity disorder in adults: an overview.
    Biological psychiatry, 2000, Jul-01, Volume: 48, Issue:1

    Topics: Adult; Age Factors; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity;

2000

Trials

1 trial available for desipramine and Remission, Spontaneous

ArticleYear
Therapy possibilities for therapy-resistant depressions.
    Pharmakopsychiatrie, Neuro-Psychopharmakologie, 1974, Volume: 7, Issue:4

    Topics: Amitriptyline; Antidepressive Agents; Chronic Disease; Clinical Trials as Topic; Depression; Desipra

1974